Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet
Boosting immunity to Omicron | Nature Medicine
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Infectious Diseases
Why are Covid vaccine boosters needed and who in the UK will receive them?
Frontiers | Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China
Covid booster doses will be offered to over-40s - BBC News
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines | The Scientist Magazine®
Rollout Strategy for the Pfizer-BioNTech COVID-19 Vaccine in Ontario - Ontario COVID-19 Science Advisory Table
COVID-19 vaccine breakthrough infections | Science
Covid booster vaccines effective against severe illness from omicron, CDC says
Vaccines | Free Full-Text | Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Pfizer says its COVID shots are 73 percent effective in children under 5 | PBS NewsHour
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022 | MMWR
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR
Durability of Bivalent Boosters against Omicron Subvariants | NEJM
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar | NEJM
